WallStreetZenWallStreetZen

NASDAQ: XRTX
Xortx Therapeutics Inc Stock Ownership - Who owns Xortx Therapeutics?

Insider buying vs selling

Have Xortx Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when XRTX insiders and whales buy or sell their stock.

XRTX Shareholders

What type of owners hold Xortx Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Dekabank Deutsche Girozentrale138.18%2,762,092$8.76MInstitution
Osaic Holdings Inc0.06%1,153$3.66kInstitution
Royal Bank Of Canada0.03%523$1.66kInstitution
Clearstead Advisors LLC0.01%277$878.09Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

XRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XRTX100.00%0.00%
PTIX2.55%1.03%Net Buying
IBIO0.72%99.28%Net Selling
ATXI0.73%15.75%Net Buying
VCNX18.31%81.69%Net BuyingNet Buying

Xortx Therapeutics Stock Ownership FAQ

Who owns Xortx Therapeutics?

Xortx Therapeutics (NASDAQ: XRTX) is owned by 138.28% institutional shareholders, 0.00% Xortx Therapeutics insiders, and 0.00% retail investors. Dekabank Deutsche Girozentrale is the largest individual Xortx Therapeutics shareholder, owning 2.76M shares representing 138.18% of the company. Dekabank Deutsche Girozentrale's Xortx Therapeutics shares are currently valued at $8.42M.

If you're new to stock investing, here's how to buy Xortx Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.